Blood and urine were obtained from male Sprague–Dawley rats and B6C3F1 mice exposed to either a single 6 h or multiple daily (5×6 h) nose-only doses of 1,3-[2,3- 14 C ]-butadiene at atmospheric concentrations of 1, 5 or 20 ppm. Globin was isolated from erythrocytes of exposed animals and analyzed for total radioactivity and also for N-(1,2,3-trihydroxybut-4-yl)-valine adducts. The modified Edman degradation procedure coupled with GC–MS was used for the adduct analysis. Linear relationships were observed between the exposures to 1,3-[2,3- 14 C ]-butadiene and the total radioactivity measured in globin and the level of trihydroxybutyl valine adducts in globin. A greater level of radioactivity (ca. 1.3-fold) was found in rat globin compared with mouse globin. When analyzed for specific amino acid adducts, higher levels of trihydroxybutyl valine adducts were found in mouse globin compared with rat globin. Average levels of trihydroxybutyl valine adduct measured in globin from rats and mice exposed for 5×6 h at 1, 5 and 20 ppm 1,3-[2,3- 14 C ]-butadiene were, respectively, for rats: 80, 179, 512 pmol/g globin and for mice: 143, 351, 1100 pmol/g globin. The profiles of urinary metabolites for rats and mice exposed at the different concentrations of butadiene were obtained by reverse phase HPLC analysis on urine collected 24 h after the start of exposure and were compared with results of a previous similar study carried out for 6 h at 200 ppm butadiene. Whilst there were qualitative and quantitative differences between the profiles for rats and mice, the major metabolites detected in both cases were those representing products of epoxide hydrolase mediated hydrolysis and glutathione (GSH) conjugation of the metabolically formed 1,2-epoxy-3-butene. These were 4-( N-acetyl- l-cysteine- S-yl)-1,2-dihydroxy butane and ( R)-2-( N-acetyl- l-cystein- S-yl)-1-hydroxybut-3-ene, 1-( N-acetyl- l-cystein- S-yl)-2-( S)-hydroxybut-3-ene, 1-( N-acetyl- l-cystein- S-yl)-2-( R)-hydroxybut-3-ene, ( S)-2-( N-acetyl- l-cystein- S-yl)-1-hydroxybut-3-ene, respectively. The former pathway showed a greater predominance in the rat. The profiles of metabolites were similar at exposure concentration in the range 1–20 ppm. There were however some subtle differences compared with results of exposure to the higher 200 ppm concentrations. Overall the results provide the basis for cross species comparison of low exposures in the range of occupational exposures, with the wealth of data available from high exposure studies.
Read full abstract